the acorda therapeutics ( n = 3 ) quarterly update is a call called called on the acorda therapeutics ( acorda ) clinical trial ( n = 3 ) and the commercial and commercial aspects of the business. we are awaiting the development of a new drug for the treatment of asymptomatic pulmonary periods and people with Parkinson s disease who are taking carbidopa/levodopa regimen. we are awaiting the development of the drug by the FDA. we are awaiting the development of an inhaled levodopa drug for symptoms of OFF periods and people with Parkinson s disease who were taking carbidopa/levo